XM tidak menyediakan perkhidmatan kepada penduduk Amerika Syarikat.

Tech stocks lift Nasdaq, S&P 500; Netflix soars after results



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>US STOCKS-Tech stocks lift Nasdaq, S&P 500; Netflix soars after results</title></head><body>

For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window.

Netflix projects continued growth through year-end

CVS falls after replacing CEO

American Express, SLB down following results

Indexes: Dow down 0.09%, S&P 500 up 0.27%, Nasdaq up 0.52%

Updated at 12:05 p.m. ET/1605 GMT

By Lisa Pauline Mattackal and Purvi Agarwal

Oct 18 (Reuters) - The S&P 500 and the tech-heavy Nasdaq gained ground on Friday, bolstered by technology stocks, while Netflix surged after exceeding subscriber growth estimates.

Shares of Netflix NFLX.O jumped 10.2% to a record high after the streaming giant topped Wall Street estimates for subscriber additions and said it expected continued growth through the end of the year.

The Dow was dragged lowerby American Express AXP.N, which lost 3.6% after its quarterly revenue missed estimates.



Meanwhile, all the so-called MagnificentSeven stocks, which have driven much of Wall Street's rally this year, rose.

Apple AAPL.O gained 1.2% after data showed a sharp increase innew iPhone sales in China, while chip heavyweight Nvidia NVDA.O added 0.6% after BofA Global Research hiked its price target on the stock.

Netflix's gains lifted the Communication Services sector .SPLRCL 1%, while Information Technology .SPLRCT rose 0.4%

An upbeat start to the quarterly earnings seasonand broadly positive economic data have put the three main indexes on track to log their sixth straight week of gains.

However, stretched valuations - the S&P 500 is trading at nearly 22 times forward earnings - along with high expectations for corporate results and potential volatility around November's U.S. presidential elections, could leave stocks vulnerable to a pullback.

"We had good earnings out of Netflix this morning, some good housing data and sentiment in general has been quite well," said Dustin Thackeray, chief investment officer, Crewe Advisors.

"Now is maybe a bit of a waiting game to see how things shake out with (the upcoming U.S. election) and then the subsequent Fed meeting a couple days later, to see if there is any sort of a pause in the coming meetings through the remainder of the year."

TheDow Jones Industrial Average .DJI fell 39.97 points, or 0.09%, to 43,199.96, the S&P 500 .SPX gained 15.92 points, or 0.27%, to 5,857.39, and the Nasdaq Composite .IXIC gained 95.02 points, or 0.52%, to 18,468.63.

The small-cap Russell 2000 .RUT was set to outperform major indexes in the week with a 2% weekly gain, although it edged down 0.1% on the day.

CVS Health CVS.N slumped 9.3% after itreplaced CEO Karen Lynch with company veteran David Joyner and withdrew its 2024 profit forecast. It was the biggest decliner on the benchmark index.

SLB SLB.N fell 3.2% following results, while Procter & Gamble PG.N rose 0.1%.

Meanwhile, U.S. listings of Chinese companies moved higher after China's centralbank launched funding schemes aimed at boosting the equity market. Alibaba BABA.N gained 1.7% andJD.com JD.O rose 2.2%.

Expectations for the U.S. Federal Reserve to ease interest rates by 25 basis points at its Novembermeeting stood intact, at about 90%, according to CME's FedWatch.

In economic data, single-family housing starts increased 2.7% to a seasonally adjusted annual rate of 1.027 million units in September.

Advancing issues outnumbered decliners by a 1.41-to-1 ratio on the NYSE, and by a 1.32-to-1 ratio on the Nasdaq.

The S&P 500 posted 42 new 52-week highs and two new lows, while the Nasdaq Composite recorded 109 new highs and 27 new lows.


Netflix returned more to shareholders in 20 years https://reut.rs/3YsYfzS


Reporting by Lisa Mattackal and Purvi Agarwal in Bengaluru; Editing by Pooja Desai

</body></html>

Penafian: Entiti XM Group menyediakan perkhidmatan pelaksanaan sahaja dan akses ke Kemudahan Dagangan Atas Talian, yang membolehkan sesorang melihat dan/atau menggunakan kandungan yang ada di dalam atau melalui laman web, tidak bertujuan untuk mengubah atau memperluas, juga tidak mengubah atau mengembangkannya. Akses dan penggunaan tersebut tertakluk kepada: (i) Terma dan Syarat; (ii) Amaran Risiko; dan Penafian Penuh. Oleh itu, kandungan sedemikian disediakan tidak lebih dari sekadar maklumat umum. Terutamanya, perlu diketahui bahawa kandungan Kemudahan Dagangan Atas Talian bukan permintaan, atau tawaran untuk melakukan transaksi dalam pasaran kewangan. Berdagang dalam mana-mana pasaran kewangan melibatkan tahap risiko yang besar terhadap modal anda.

Semua bahan yang diterbitkan di Kemudahan Dagangan Atas Talian kami bertujuan hanya untuk tujuan pendidikan/maklumat dan tidak mengandungi – dan tidak boleh dianggap mengandungi nasihat kewangan, cukai pelaburan atau dagangan dan cadangan, atau rekod harga dagangan kami, atau tawaran, atau permintaan untuk suatu transaksi dalam sebarang instrumen kewangan atau promosi kewangan yang tidak diminta kepada anda.

Sebarang kandungan pihak ketiga serta kandungan yang disediakan oleh XM, seperti pendapat, berita, penyelidikan, analisis, harga, maklumat lain atau pautan ke laman web pihak ketiga yang terdapat dalam laman web ini disediakan berdasarkan "seadanya" sebagai ulasan pasaran umum dan bukanlah nasihat pelaburan. Sesuai dengan apa-apa kandungan yang ditafsir sebagai penyelidikan pelaburan, anda mestilah ambil perhatian dan menerima bahawa kandungan tersebut tidak bertujuan dan tidak sediakan berdasarkan keperluan undang-undang yang direka untuk mempromosikan penyelidikan pelaburan bebas dan oleh itu, ia dianggap sebagai komunikasi pemasaran di bawah peraturan dan undang-undang yang berkaitan. SIla pastikan bahawa anda telah membaca dan memahami Notifikasi mengenai Penyelidikan Pelaburan Bukan Bebas dan Amaran Risiko mengenai maklumat di atas yang boleh diakses di sini.

Amaran Risiko: Modal anda dalam risiko. Produk yang berleveraj mungkin tidak sesuai untuk semua individu. Sila pertimbangkan Pendedahan Risiko kami.